# M-2018-334 in Hematological Malignancies

> **NCT06225050** · NA · NOT_YET_RECRUITING · sponsor: **Miltenyi Biomedicine GmbH** · enrollment: 18 (estimated)

## Conditions studied

- Hematological Malignancies

## Interventions

- **DEVICE:** CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version)

## Key facts

- **NCT ID:** NCT06225050
- **Lead sponsor:** Miltenyi Biomedicine GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-28
- **Primary completion:** 2029-02-28
- **Final completion:** 2029-02-28
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06225050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06225050, "M-2018-334 in Hematological Malignancies". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06225050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*